Agenda Sessions

October 26, 2008

4:00 p.m. -	Registration Opens (Grand Foyer)
4:00 p.m. - 7:00 p.m.	Parnering Opens Meetings will take place on the third floor; Obtain schedules and keys at partnering desk in Grand Foyer
7:00 p.m. - 8:30 p.m.	Opening Reception (Palm Court)

October 27, 2008

7:00 a.m. -

Registration Opens (Grand Foyer)

8:00 a.m. - 9:25 a.m.

Breakfast Plenary (Pavilion)

Alternative Financing: Raising Money in Today's Marketplace

Given the state of the IPO market and the challenges of raising money in today's climate, this panel will focus on alternative financing options and the implications of pursuing these options with regard to running your business and managing shareholder value and dilution.

Moderator:
Standish Fleming, Managing Member, Forward Ventures

Panelists:
Andrew Busser, Principal, Symphony Capital, LLC
John Chambers, Head of Health Care Investment Banking, Merriman Curhan Ford
Matthew Q. Reber, Vice President, Cowen Healthcare Royalty Partners
Todd Wyche, Managing Director, Brinson Patrick Securities Corporation

9:30 a.m. - 12:25 a.m.

Company Presentations

PUBLIC COMPANIES (Aventine Ballroom C)	PRIVATE (Aventine Ballroom B)
Track One	Track Two
9:30am Genoptix	9:30am Ambrx, Inc.
10:00am Cytori	10:00am Tracon Pharmaceuticals
10:30am Avanir Pharmaceuticals	10:30am Phenomix Corp.
11:00am Inovio Biomedical Corporation	11:00am Regulus Therapeutics LLC
11:30am Anadys Pharmaceuticals, Inc.	11:30am Regenemed, Inc.
12:00pm Gen-Probe Incorporated	12:00pm Ambit Biosciences

9:30 a.m. - 6:00 p.m.

Partnering

Meetings will take place on the third floor; Obtain schedules and keys at partnering desk in Grand Foyer

12:30 p.m. - 1:45 p.m.

Lunch Plenary (Pavilion)

Keynote Speaker:

Stelios Papadopoulos, Ph.D., Chairman of the Board/Director/Founder, Exelixis Inc.

2:00 p.m. - 6:00 p.m.

Company Presentations

PUBLIC COMPANIES (Aventine Ballroom C)	PRIVATE COMPANIES (Aventine Ballroom B)
Track One	Track Two
2:00pm Halozyme	2:00pm AltheaDx
2:30pm Adventrx	2:30pm Theragen
3:00pm Metabasis	3:00pm Mpex
3:30pm Volcano	3:30pm Amira
4:00pm Invitrogen	4:00pm Asphelia
4:30pm Hollis-Eden Pharmaceuticals	4:30pm DermTech
5:00pm Spectrum	5:00pm Novocell
5:30pm Alphatec Spine	5:30pm Ultimate Lab

6:00 p.m. - 7:30 p.m.

Networking Reception (Barcino Restaurant)

October 28, 2008

8:00 a.m. - 9:25 a.m.

Breakfast Plenary (Pavilion)

Keynote Speaker:

Jeremy Levin, Senior Vice President, Strategic Transactions, Bristol-Myers Squibb Company

9:30 a.m. - 12:25 p.m.

Company Presentations

PUBLIC COMPANIES (Aventine Ballroom C)	PRIVATE COMPANIES (Aventine Ballroom B)
Track One	Track Two
9:30am Cadence	9:30am Anaptys
10:00am Transdel	10:00am GenVault
10:30am Amylin	10:30am KAER Therapeutics
11:00am Vical, Inc.	11:00am Braincells
11:30am Epicept	11:30am Histogen
12:00pm Isis	12:00pm Avitacor

9:30 a.m. - 5:00 p.m.

Partnering

Meetings will take place on the third floor; obtain schedules and keys at partnering desk in Grand Foyer

12:30 p.m. - 1:55 p.m.

Lunch Plenary (Pavilion)

The Last Word from the Street: A View of the Biotech Industry in 2009

A panel of industry experts discuss their thoughts on the key issues and events that will affect the industry in the coming twelve to eighteen months. What impact will the bailout election have on investor confidence? How is the FDA affecting investor confidence and will that change? What are the emerging catalysts for the biotech industry? Which technologies, products or corporate strategies will attract investor interest?

Panelists:
Evan McCulloch, Portfolio Manager, Franklin Templeton Investments
Matthew Perry, Portfolio Manager, Biotechnology Value Fund, L.P.
Kurt von Emster, General Partner, MPM Capital
Robert J. More, General Partner, Frazier Healthcare Ventures

Moderator:
Larry Stambaugh, Apercu Consulting

2:00 p.m. - 5:00 p.m.

Company Presentations

PUBLIC COMPANIES (Aventine Ballroom C)	PRIVATE COMPANIES (Aventine Ballroom B)
Track One	Track Two
2:00pm Arena	2:00pm Vitreoretinal
2:30pm AMN Healthcare	2:30pm BioAtom
3:00pm Nventa	3:00pm CalciMedica
3:30pm Acadia	3:30pm VentiRx
4:00pm Orexigen	4:00pm Pico Pharmaceuticals
4:30pm Automedics Medical Systems	4:30pm Medipacs, Inc.